The six-amino-acid lactoferricin B fragment (RRWQWR) enters E. coli cells and artificial membranes without causing membrane damage, overturning the assumption that antimicrobial peptides must destroy bacterial membranes to kill bacteria.
Zero membrane damageThe peptide crossed both bacterial and artificial membranes without any leakage of encapsulated markers — a striking departure from the membrane-lysis model
What the researchers found
LfcinB (4-9), with the sequence RRWQWR, entered E. coli cytoplasm without inducing membrane leakage. This was demonstrated by two independent methods: (1) SYTOX green exclusion showed no membrane damage, and (2) fluorescently labeled peptide entered cells without leakage of the cytoplasmic marker calcein.
The same behavior was observed in artificial membrane vesicles (GUVs) — the labeled peptide translocated across the lipid bilayer without leakage of the encapsulated probe AF647. Interaction with DNA significantly increased the peptide's fluorescence intensity, suggesting intracellular DNA binding as a potential antimicrobial mechanism.
Why it matters
Understanding how antimicrobial peptides actually kill bacteria is essential for designing better peptide antibiotics. If small peptides can enter bacteria without membrane disruption, it means they work through intracellular targets like DNA — a completely different mechanism than membrane lysis. This opens new strategies for designing peptide antibiotics that might be effective even against bacteria that can reinforce their membranes.
How the study worked
Fluorescently labeled LfcinB (4-9) (Rh-LfcinB) was studied using confocal microscopy in two systems: (1) live E. coli cells pre-loaded with calcein as a leakage marker, and (2) giant unilamellar vesicles (GUVs) made from bacterial-like lipids (DOPG/DOPC) containing the fluorescent probe AF647. SYTOX green assays monitored membrane integrity. DNA-peptide interactions were assessed by fluorescence changes upon binding.
What this study cannot tell us
The study was conducted entirely in vitro using a single bacterial species (E. coli) and artificial membrane vesicles. The exact intracellular target and killing mechanism were not definitively established — DNA binding was demonstrated but its role in cell death was not confirmed. The peptide concentrations used may not reflect physiologically achievable levels. Only one peptide fragment was studied.
How to read the evidence
This is a mechanistic biophysics study using sophisticated single-vesicle and single-cell microscopy techniques. The evidence for membrane translocation without damage is strong, but the downstream killing mechanism remains to be fully elucidated.
When this study was published
Published in 2017, this study challenged prevailing assumptions about antimicrobial peptide mechanisms and has influenced subsequent research on cell-penetrating antimicrobial peptides.
The bigger picture
The dominant model of antimicrobial peptide action — the 'barrel-stave' or 'carpet' model of membrane disruption — has been challenged by this and similar studies showing that some peptides work intracellularly. This is significant because intracellular targets offer different selectivity profiles and resistance mechanisms. A peptide that kills bacteria by binding DNA, for instance, would be difficult for bacteria to resist without fundamentally altering their genetic material.
Questions still open
- Is DNA binding the actual mechanism of killing, or does the peptide interact with other intracellular targets?
- Does this membrane-crossing, non-lytic mechanism also apply to other antimicrobial peptides derived from lactoferrin?
- Can this cell-penetrating property be exploited to carry drug payloads into bacteria as a delivery strategy?
Common questions
If this peptide doesn't damage bacterial membranes, how might it kill bacteria?
What is lactoferricin B and where does it come from?
Read the original research
Entry of a Six-Residue Antimicrobial Peptide Derived from Lactoferricin B into Single Vesicles and Escherichia coli Cells without Damaging their Membranes.
Biochemistry, 56(33), 4419-4431
Citation
Moniruzzaman, Md; Islam, Md Zahidul; Sharmin, Sabrina; Dohra, Hideo; Yamazaki, Masahito. (2017). Entry of a Six-Residue Antimicrobial Peptide Derived from Lactoferricin B into Single Vesicles and Escherichia coli Cells without Damaging their Membranes.. Biochemistry, 56(33), 4419-4431. https://doi.org/10.1021/acs.biochem.6b01274